Kumar, Rajesh, Sunil Kumar Singh, Shruti Singh, and Alok Kumar. “Addressing Cardio-Metabolic Risks in Type 2 Diabetes: Evidence-Based Insights on Efpeglenatide”. International Journal of Basic & Clinical Pharmacology 14, no. 4 (June 24, 2025): 565–582. Accessed October 23, 2025. https://www.ijbcp.com/index.php/ijbcp/article/view/5828.